Hythiam, Inc. · Los Angeles, CA United States ·(NASDAQ (GM): HYTM)
Company Description
Hythiam specializes in researching, developing, and licensing medical protocols for the treatment of alcohol and drug addiction. The company's PROMETA treatment programs utilize a combination of medication, nutritional supplements, and counseling to treat drug and alcohol addiction. Hythiam's PROMETA Centers are operated through management or licensing agreements with health care providers in the US. PROMETA also provides maintenance support by offering individualized care programs following medically supervised treatment. Its Catasys program offers disease management services. The company owns a controlling stake in managed behavioral health provider
Key Hythiam, Inc. Financials
| Company Type | Public - NASDAQ (GM): HYTM Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $41.2 |
| 2008 Employees | 81 |
Hythiam, Inc. Executives
| Title | Name & Bio | Contact |
| Chairman and CEO | Terren Peizer | Network |
| President, COO, and Director | Richard Anderson | Network |
| CFO | Maurice Hebert | Network |
